Loading clinical trials...
Loading clinical trials...
Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium
Conditions
Interventions
Nothing
Locations
1
United States
National Jewish Health
Denver, Colorado, United States
Start Date
December 14, 2014
Primary Completion Date
December 31, 2020
Completion Date
December 31, 2020
Last Updated
April 29, 2021
Lead Sponsor
National Jewish Health
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions